Primary replacement for the management of exposed orbital implant

References

• Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthal Plast Reconstr Surg. 2007;23(1):1–7. doi:10.1097/01.iop.0000249432.18688.ee.
   PubMed Web of Science ®Google Scholar
• McElnea EM, Ryan A, Fulcher T. Porous orbital implant exposure: the influence of surgical technique. Orbit. 2014;33(2):104–108. doi:10.3109/01676830.2013.851706.
   PubMedGoogle Scholar
• Viswanathan P, Sagoo MS, Olver JM. UK national survey of enucleation, evisceration and orbital implant trends. Br J Ophthalmol. 2007;91(5):616–619. doi:10.1136/bjo.2006.103937.
   PubMed Web of Science ®Google Scholar
• Lin C, Liao S. Long-term complications of different porous orbital implants: a 21-year review. Br J Ophthalmol. 2017;101(5):681–685. doi:10.1136/bjophthalmol-2016-308932.
   PubMed Web of Science ®Google Scholar
• Jordan DR, Klapper SR, Gilberg SM, Dutton JJ, Wong A, Mawn L. The bioceramic implant: evaluation of implant exposures in 419 implants. Ophthal Plast Reconstr Surg. 2010;26(2):80–82. doi:10.1097/IOP.0b013e3181b80c30.
   PubMed Web of Science ®Google Scholar
• Sagoo MS, Rose GE. Mechanisms and treatment of extruding intraconal implants: socket aging and tissue restitution (the “Cactus Syndrome”). Arch Ophthalmol. 2007;125(12):1616–1620. doi:10.1001/archopht.125.12.1616.
   PubMedGoogle Scholar
• Jordan DR, Chan S, Mawn L. et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology. 1999;106:505–512. doi:10.1016/S0161-6420(99)90108-2.
   PubMed Web of Science ®Google Scholar
• Yoon JS, Lew H, Kim SJ, Lee SY. Exposure rate of hydroxyapatite orbital implants. A 15-year experience of 802 cases. Ophthalmology. 2008;115(3):566–572. doi:10.1016/j.ophtha.2007.06.014.
   PubMed Web of Science ®Google Scholar
• Sagoo MS, Olver JM. Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure. Br J Ophthalmol. 2004;88(7):942–946. doi:10.1136/bjo.2003.026823.
   PubMed Web of Science ®Google Scholar
• Turner LD, Haridas AS, Sullivan TJ. The versatility of the temporoparietal fascial graft (TPFG) in orbital implant exposure. Orbit. 2014;33(5):352–355. doi:10.3109/01676830.2014.904382.
   PubMedGoogle Scholar
• Pelletier CR, Jordan DR, Gilberg SM. Use of temporalis fascia for exposed hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg. 1998;14(3):198–203. doi:10.1097/00002341-199805000-00010.
   PubMed Web of Science ®Google Scholar
• Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol. 1992;113:669–673. doi:10.1016/S0002-9394(14)74792-0.
   PubMed Web of Science ®Google Scholar
• El-Shahed F, Sherif M, Ali A. Management of tissue breakdown and exposure associated with orbital hydroxyapatit implants. Ophthalmic Plast Reconstr Surg. 1995;11:91–94.
   PubMed Web of Science ®Google Scholar
• Neuhaus RW, Shorr N. Use of temporal fascia and muscle as an autograft. Arch Ophthalmol. 1983;101(2):262–264. doi:10.1001/archopht.1983.01040010264017.
   PubMedGoogle Scholar
• Oestreicher JH. Treatment of exposed coral implant after failedscleral patch graft. Ophthal Plast Reconstr Surg. 1994;10(2):110–113. doi:10.1097/00002341-199406000-00007.
   PubMed Web of Science ®Google Scholar
• Wiggs EO, Becker BB. Extrusion of enucleation implants: treatment with secondary implants and autogenous temporalis fascia or fascia lata patch grafts. Ophthalmic Surg. 1992;23:472–476.
   PubMedGoogle Scholar
• Soparkar CNS, Patrinely JR. Tarsal patch-flap for orbital implant exposure. Ophthal Plast Reconstr Surg. 1998;6:391–397. doi:10.1097/00002341-199811000-00002.
   Web of Science ®Google Scholar
• Bi X, Zhou H, Lin M, Fan X. One-stage replacement surgery of orbital implants with noninfectious complications. J Craniofac Surg. 2012;23(2):e146–e149. doi:10.1097/SCS.0b013e31824cdc5a.
   PubMed Web of Science ®Google Scholar
• Toft PB, Roed Rasmussen ML, Prause JU. One-stage explant-implant procedure of exposed porous orbital implants. Acta Ophthalmol. 2012;90(3):210–214. doi:10.1111/j.1755-3768.2010.01914.x.
   PubMed Web of Science ®Google Scholar
• Lee BJ, Lewis CD, Perry JD. Exposed porous orbital implants treated with simultaneous secondary implant and dermis fat graft. Ophthal Plast Reconstr Surg. 2010;26(4):273–276. doi:10.1097/IOP.0b013e3181bf24db.
   PubMed Web of Science ®Google Scholar
• Jordan DR, Brownstein S, Faraji H. Clinicopathologic analysis of 15 explanted hydroxyapatite implants. Ophthal Plast Reconstr Surg. 2004;20(4):285–290. doi:10.1097/01.IOP.0000131735.89093.22.
   PubMed Web of Science ®Google Scholar
• Jordan DR, Brownstein S, Jolly SS. Abscessed hydroxyapatite orbital implants: A report of two cases. Ophthalmology. 1996;103:1784–1787. doi:10.1016/S0161-6420(96)30427-2.
   PubMed Web of Science ®Google Scholar
• Ainbinder DJ, Haik BG, Tellado M. Hydroxy apatite orbital implant abscess: histopathologic correlation of an infected implant following evisceration. Ophthal Plast Reconstr Surg. 1994;10:267–270. doi:10.1097/00002341-199412000-00009.
   PubMed Web of Science ®Google Scholar
• Jordan DR, Brownstein S, Rawlings N, Robinson J. An infected porous polyethylene orbital implant. Ophthal Plast Reconstr Surg. 2007;23(5):413–415. doi:10.1097/IOP.0b013e318137a600.
   PubMed Web of Science ®Google Scholar
• Jordan DR, Brownstein S, Robinson J. Infected aluminum oxide orbital implant. Ophthal Plast Reconstr Surg. 2006;22(1):66–67. doi:10.1097/01.iop.0000197018.44245.7e.
   PubMed Web of Science ®Google Scholar
• Rasmussen MLR, Ekholm O, Prause JU, Toft PB. Quality of life of eye amputated patients. Acta Ophthalmol. 2012;90:435–440. doi:10.1111/j.1755-3768.2010.02092.x.
   PubMed Web of Science ®Google Scholar
• Ahn JM, Lee SY, Yoon JS. Health-related quality of life and emotional status of anophthalmic patients in Korea. Am J Ophthalmol. 2010;90:435–440. doi:10.1016/j.ajo.2009.12.036.
   Web of Science ®Google Scholar
• Masdottir S, Sahlin S. Patient satisfaction and results after evisceration with a split-sclera technique. Orbit. 2007;26:241–247. doi:10.1080/01676830600985916.
   PubMedGoogle Scholar
• McBain HB, Ezra DG, Rose GE. et al. The psychosocial impact of living with an ocular prosthesis. Orbit. 2014;33:33–39. doi:10.3109/01676830.2013.851251.
   PubMedGoogle Scholar
• Salour H, Owji N, Farahi A. Two-stage procedure for management of large exposure defects of hydroxyapatite orbital implant. Eur J Ophthalmol. 2003;9–10:789–793. doi:10.1177/1120672103013009-1010.
   Web of Science ®Google Scholar
• Kim HK, La TY. Treatment of intractable orbital implant exposure with a large conjunctival defect by secondary insertion of the implant after preceding dermis fat graft. Int J Ophthalmol. 2013;6:193–197. doi:10.3980/j.issn.2222-3959.2013.02.17.
   PubMed Web of Science ®Google Scholar
• Chuo JY, Dolman PJ, Ng TL, Buffam FV, White VA. Clinical and histopathologic review of 18 explanted porous polyethylene orbital implants. Ophthalmology. 2009;116(2):349–354. doi:10.1016/j.ophtha.2008.09.022.
   PubMed Web of Science ®Google Scholar